KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomarin Pharmaceutical (BMRN) Land & Improvements: 2010-2013

Historic Land & Improvements for Biomarin Pharmaceutical (BMRN) over the last 2 years, with Dec 2013 value amounting to $74.9 million.

  • Biomarin Pharmaceutical's Land & Improvements rose 33.81% to $74.9 million in Q4 2013 from the same period last year, while for Dec 2013 it was $74.9 million, marking a year-over-year increase of 33.81%. This contributed to the annual value of $74.9 million for FY2013, which is 33.81% up from last year.
  • Per Biomarin Pharmaceutical's latest filing, its Land & Improvements stood at $74.9 million for Q4 2013, which was up 18.66% from $63.2 million recorded in Q3 2013.
  • Over the past 5 years, Biomarin Pharmaceutical's Land & Improvements peaked at $74.9 million during Q4 2013, and registered a low of $37.7 million during Q4 2010.
  • Over the past 3 years, Biomarin Pharmaceutical's median Land & Improvements value was $56.0 million (recorded in 2012), while the average stood at $57.1 million.
  • Data for Biomarin Pharmaceutical's Land & Improvements shows a peak YoY spiked of 33.81% (in 2013) over the last 5 years.
  • Quarterly analysis of 4 years shows Biomarin Pharmaceutical's Land & Improvements stood at $37.7 million in 2010, then rose by 28.99% to $48.6 million in 2011, then increased by 15.33% to $56.0 million in 2012, then soared by 33.81% to $74.9 million in 2013.
  • Its Land & Improvements stands at $74.9 million for Q4 2013, versus $63.2 million for Q3 2013 and $60.4 million for Q2 2013.